During our investigation into the anti-colorectal cancer activity of obatoclax, Koheler et al. [26] published a report showing that obatoclax at subtoxic dosage caused G1-phase arrest accompanied by cyclin D1 downregulation and delayed cell proliferation in HT-29 cells [26]. The gene discussed is CCND1; the disease is colorectal cancer.